Showing 1 - 7 results of 7 for search 'Jodi L McBride', query time: 0.03s Refine Results
  1. 1
    Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease

    Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease by Brett D. Dufour, Jodi L. McBride

    Published 2019-01-01
    Get full text
    Article
  2. 2
    The macaque brain ONPRC18 template with combined gray and white matter labelmap for multimodal neuroimaging studies of Nonhuman Primates

    The macaque brain ONPRC18 template with combined gray and white matter labelmap for multimodal neuroimaging studies of Nonhuman Primates by Alison R. Weiss, Zheng Liu, Xiaojie Wang, William A. Liguore, Christopher D. Kroenke, Jodi L. McBride

    Published 2021-01-01
    Get full text
    Article
  3. 3
    Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease

    Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease by Shilpa Ramaswamy, Jodi L. McBride, Christopher D. Herzog, Eugene Brandon, Mehdi Gasmi, Raymond T. Bartus, Jeffrey H. Kordower

    Published 2007-05-01
    Get full text
    Article
  4. 4
    Alterations of fractional anisotropy throughout cortico-basal ganglia gray matter in a macaque model of Huntington’s Disease

    Alterations of fractional anisotropy throughout cortico-basal ganglia gray matter in a macaque model of Huntington’s Disease by Alison R. Weiss, William A. Liguore, Kristin Brandon, Xiaojie Wang, Zheng Liu, Christopher D. Kroenke, Jodi L. McBride

    Published 2023-01-01
    Get full text
    Article
  5. 5
    Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's disease

    Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's disease by Shilpa Ramaswamy, Jodi L. McBride, Ina Han, Elizabeth M. Berry-Kravis, Lili Zhou, Christopher D. Herzog, Mehdi Gasmi, Raymond T. Bartus, Jeffrey H. Kordower

    Published 2009-04-01
    Get full text
    Article
  6. 6
    A novel rhesus macaque model of Huntington’s disease recapitulates key neuropathological changes along with motor and cognitive decline

    A novel rhesus macaque model of Huntington’s disease recapitulates key neuropathological changes along with motor and cognitive decline by Alison R Weiss, William A Liguore, Kristin Brandon, Xiaojie Wang, Zheng Liu, Jacqueline S Domire, Dana Button, Sathya Srinivasan, Christopher D Kroenke, Jodi L McBride

    Published 2022-10-01
    Get full text
    Article
  7. 7
    Discovery of a CLN7 model of Batten disease in non-human primates

    Discovery of a CLN7 model of Batten disease in non-human primates by Jodi L. McBride, Martha Neuringer, Betsy Ferguson, Steven G. Kohama, Ian J. Tagge, Robert C. Zweig, Laurie M. Renner, Trevor J. McGill, Jonathan Stoddard, Samuel Peterson, Weiping Su, Larry S. Sherman, Jacqueline S. Domire, Rebecca M. Ducore, Lois M. Colgin, Anne D. Lewis

    Published 2018-11-01
    Get full text
    Article

Search Tools: